Opioid Management and Dependency Among Adult Patients with Sickle Cell Disease

REFERENCES

• American Pain Society. Pain: the fifth vital sign. 1995. www:ampainsoc.org/advocacy/fifth (January 2011).
   Google Scholar
• National Pharmaceutical Council & Joint Commission on Accreditation of Healthcare Organizations. Pain: current understanding of assessment, management and treatment. 2001. www.jcaho.org.
   Google Scholar
• Green C. Racial disparities in access to pain treatment. Pain Clin Updates. 2004;12(6):1–4.
   Google Scholar
• Feliu M, Edwards CL. Psychologic factors in the development of complex regional pain syndrome: history, myth and evidence. Clin J Pain. 2010;26(3):258–263.
   PubMed Web of Science ®Google Scholar
• Wailoo K. Stigma, race, and disease in 20th century America. Lancet. 2006;367(9509):531–533.
   PubMed Web of Science ®Google Scholar
• Wright K, Adeosun O. Barriers to effective pain management in sickle cell disease. Br J Nursing. 2009;18(3):158–161.
   PubMedGoogle Scholar
• Kamble S, Telen MJ, Dinan MA, Grussemeyer CA, Reed SD. Costs and length of stay in patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement. Am J Hematol. 2011;86(1):79–81.
   PubMedGoogle Scholar
• Okpala I, Tawil A. Management of pain in sickle cell disease. J Roy Soc Med. 2002;95(9):456–458.
   PubMed Web of Science ®Google Scholar
• Stinson J, Naser B. Pain management in children with sickle cell disease. Paediatr Drugs. 2003;5(4):229–241.
   PubMedGoogle Scholar
• Stuart MJ, Nagel R. Sickle cell disease. Lancet. 2004;364(9442):1343–1360.
   PubMed Web of Science ®Google Scholar
• Edwards CL, Scales M, Loughlin C, A brief review of the pathophysiology, associated pain and psychosocial issues associated with sickle cell disease. Int J Behav Med. 2005;12(3):171–179.
   PubMed Web of Science ®Google Scholar
• Levenson JL, McClish DK, Dahman BA, Depression and anxiety in adults with sickle cell disease: The PiSCES Project. Psychosom Med. 2008;70(2):192–196.
   PubMed Web of Science ®Google Scholar
• Quinn CT, Rogers AR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115(17):3447–3452.
   PubMed Web of Science ®Google Scholar
• Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood. 2005;103(11):4023–4027.
   Web of Science ®Google Scholar
• Brousseau DC, Panepinto JA, Nimmer M, Hoffman RG. The number of people with sickle cell disease in the United States: national and state estimates. Am J Hematol. 2010;85(1):77–78.
   PubMed Web of Science ®Google Scholar
• Steinberg MH, Barton F, Castro O, Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 2003;289(13):1645–1651.
   PubMed Web of Science ®Google Scholar
• Pegelow C. Survey of pain management therapy provided for children with sickle cell disease. Clin Pediatr (Phila). 1992;31(4):211–4.
   PubMed Web of Science ®Google Scholar
• Salomon LR. Pain management in adults with sickle cell disease in a medical center emergency department. J Natl Med Assoc. 2010;102(11):1025–1032.
   PubMed Web of Science ®Google Scholar
• Yale SH, Nagib N, Guthrie T. Approach to vaso-oclussive crisis in adults with sickle cell disease. Amer Fam Phys. 2000.http://www.aafp.org/afp20000301/1349.html.
   Google Scholar
• Smith WR, Penberthy LT, Bovbjerg VE, Daily assessment of pain in adults with sickle cell disease. Ann Intern Med. 2008;148(2):94–101.
   PubMed Web of Science ®Google Scholar
• Jerrell JM, Tripathi A, Stallworth JR. Pain management in children and adolescents with sickle cell disease. Am J Hematol. 2011;86(1):82–84.
   PubMed Web of Science ®Google Scholar
• Schecter NL, Berrien FB, Katz SM. The use of patient-controlled analgesia in sickle cell pain crisis: a preliminary report. J Pain Symptom Manage. 1988;3(3):109–113.
   PubMedGoogle Scholar
• Ballas SK, Lusardi M. Hospital readmission for adult sickle cell painful episodes: frequency, etiology and prognosis significance. Am J Hematol. 2005;79(1):17–25.
   PubMed Web of Science ®Google Scholar
• Ballas S. Self-management of sickle cell disease: a new frontier. J Natl Med Assoc. 2010;102(11):1042–1043.
   PubMed Web of Science ®Google Scholar
• Pack-Mabien A, Labbe E, Herbert D, Haynes J. Nurses attitudes and practices in sickle cell pain management. Appl Nurs Res. 2001;14(4):187–192.
   PubMed Web of Science ®Google Scholar
• Shapiro BS, Benjamin LJ, Payne R, Heidrich G. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manage. 1997;14(3):168–174.
   PubMed Web of Science ®Google Scholar
• Payne R. Pain management in sickle cell disease: rationale and techniques. Ann NY Acad Sci. 1989;565:189–203.
   PubMed Web of Science ®Google Scholar
• Weissman DE, Haddock JD. Opioid pseudoaddiction–an iatrogenic syndrome. Pain. 1989;36(3):363–366.
   PubMed Web of Science ®Google Scholar
• U.S. National Institutes of Health, National Cancer Institute (2004). Substance abuse issues in cancer. http://www.cancer.gov/cancertopics/pdq/supportivecare/substanceabuse/HealthProfessional/page3.
   Google Scholar
• American Pain Society. Guideline for the management of acute and chronic pain in sickle cell disease. August 1999.
   Google Scholar
• Neumayr L, Pringle S, Giles S, Chart Card: feasibility of a tool for improving emergency department care in sickle cell disease. J Natl Med Assoc. 2010;102(11):1017–1023.
   PubMed Web of Science ®Google Scholar
• Booker MJ, Blethyn KL, Wright CJ, Greenfield SM. Pain management in sickle cell. Chronic Illn. 2006;2(1):39–50.
   PubMedGoogle Scholar
• Malach S, Levin T, Saravay S, Martin, R, Rao, S, Horowitz, D. Sickle cell disease–when opioids and physicians fail. Gen Hosp Psychiatry. 2002; 24(6):442–447.
   PubMed Web of Science ®Google Scholar
• Elander J, Lusher J, Bevan D. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. J Pain Symptom Manage. 2004;27(2):156–169.
   PubMed Web of Science ®Google Scholar
• Lotsch J, Geisslinger G, Tegeder I. Genetic modulation of the pharmacological treatment of pain. Pharmacol Ther. 2009;124(2):168–184.
   PubMed Web of Science ®Google Scholar
• May A. Chronic pain may change the structure of the brain. Pain. 2008;137(1):7–15.
   PubMed Web of Science ®Google Scholar
• Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926.
   PubMed Web of Science ®Google Scholar
• Moore JE. Chronic low back pain and psychosocial issues. Phys Med Rehab Clin N Am. 2010:21(4);801–815.
   PubMed Web of Science ®Google Scholar
• Edwards L, Edwards CL. Psychosocial treatments in pain management of sickle cell disease. J Natl Med Assoc. 2010;102(11):1084–1094.
   PubMed Web of Science ®Google Scholar
• Wellington C, Edwards CL, McNeill J, Somatization in the conceptualization of sickle cell disease. J Natl Med Assoc. 2010;102(11):1079–1083.
   PubMed Web of Science ®Google Scholar
• Sambo CF, Howard M, Kopelman M, Williams S, Fotopoulou A. Knowing you care: effects of perceived empathy and attachment style on pain perception. Pain. 2010;151(3):687–693.
   PubMed Web of Science ®Google Scholar
• Jenerette C, Funk M, Murdaugh C. Sickle cell disease: a stigmatizing condition that may lead to depression. Issues Ment Health Nurs. 2005;26(10):1081–1101.
   PubMedGoogle Scholar
• Cohen S. Social relationships and health. Am Psychol. 2004;59(8):676–684.
   PubMed Web of Science ®Google Scholar
• Harrison, OM, Edwards, CL, Koenig HG, Bosworth, HB, DeCastro, L, Wood, M. Religiosity/spirituality and pain in patients with sickle cell disease. J Nerv Ment Dis. 2005:193(4):250–257.
   PubMed Web of Science ®Google Scholar
• Pells JJ, Presnell KE, Edwards CL, Moderate chronic pain, weight and dietary intake in African-American adult patients with sickle cell disease. J Natl Med Assoc. 2005;97(12):1622–1629.
   PubMedGoogle Scholar
• Martins SS, Storr CL, Zhu H, Chilcoat HD. Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population. Drug Alcohol Depend. 2009;99(1-3):58–67.
   PubMed Web of Science ®Google Scholar
• Kaufmann CA, Kreek MJ, Karoum F, Chuang LW. Depression during methadone withdrawal: no role for B-phenylethylamine. Drug Alcohol Depend. 1984;13(1):21–29.
   PubMed Web of Science ®Google Scholar